心胸血管外科
術前貧血管理和紅細胞量的優化
Ferric carboxymaltose in patients with heart failure and iron deficiency. （開啟新視窗）
來源: N Engl J Med 2009;361(25):2436-48.
檢索: PubMed 19920054
DOI碼: 10.1056/NEJMoa0908355
Successful repair of a giant abdominal aortoiliac aneurysm in a Jehovah's Witness. （開啟新視窗）
來源: Vasc Endovascular Surg 2007;41(5):460-2.
檢索: PubMed 17942864
DOI碼: 10.1177/1538574407303172
Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. （開啟新視窗）
來源: Catheter Cardiovasc Interv 2014;83(6):E221-6.
檢索: PubMed 24402965
DOI碼: 10.1002/ccd.25389
Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. （開啟新視窗）
來源: Anesth Analg 2019;128(5):981-92.
檢索: PubMed 30649068
DOI碼: 10.1213/ANE.0000000000004005
Epoetin dosing for blood conservation in Jehovah's Witness patients undergoing cardiac surgery—a systematic review. （開啟新視窗）
來源: Can J Cardiol 2014;30(Suppl):S234.
DOI碼: 10.1016/j.cjca.2014.07.398
http://www.onlinecjc.ca/article/S0828-282X(14)00876-9/abstract （開啟新視窗）
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. （開啟新視窗）
來源: Am J Cardiol 2012;110(7):1021-6.
檢索: PubMed 22771376
DOI碼: 10.1016/j.amjcard.2012.05.036
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. （開啟新視窗）
來源: Eur J Heart Fail 2013;15(11):1267-76.
檢索: PubMed 23787722
DOI碼: 10.1093/eurjhf/hft099
Current status of pharmacologic therapies in patient blood management. （開啟新視窗）
來源: Anesth Analg 2013;116(1):15-34.
檢索: PubMed 23223098
DOI碼: 10.1213/ANE.0b013e318273f4ae
Intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. （開啟新視窗）
來源: J Cardiothorac Vasc Anesth 2016;30(2):363-72.
檢索: PubMed 26809765
DOI碼: 10.1053/j.jvca.2015.10.021
The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. （開啟新視窗）
來源: Transfusion 2008;48(4):666-72.
檢索: PubMed 18194382
DOI碼: 10.1111/j.1537-2995.2007.01590.x
Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). （開啟新視窗）
來源: Br J Anaesth. 2022;128(5):796-805.
檢索: PubMed 35256150
DOI碼: 10.1016/j.bja.2022.01.034
Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. （開啟新視窗）
來源: Transfus Med Rev 2013;27(4):221-34.
檢索: PubMed 24135037
DOI碼: 10.1016/j.tmrv.2013.09.001
The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2013;146(6):1480-7.e6.
檢索: PubMed 23998782
DOI碼: 10.1016/j.jtcvs.2013.06.033
Jehovah's Witnesses and cardiac surgery: a single institution's experience. （開啟新視窗）
來源: Transfusion 2014;54(10 Pt 2):2745-52.
檢索: PubMed 24809815
DOI碼: 10.1111/trf.12696
Determining optimal treatment to correct preoperative anemia and reduce perioperative allogeneic blood transfusions in cardiac surgery: a retrospective cohort study. （開啟新視窗）
來源: J Cardiothorac Vasc Anesth 2021;35(9):2631-9.
檢索: PubMed 33483268
DOI碼: 10.1053/j.jvca.2020.12.044
Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. （開啟新視窗）
來源: Surg Infect (Larchmt) 2009;10(1):9-19.
檢索: PubMed 19245362
DOI碼: 10.1089/sur.2008.043
Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial. （開啟新視窗）
來源: Anaesthesia 2020;75(8):1039-49.
檢索: PubMed 32342498
DOI碼: 10.1111/anae.15062
Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. （開啟新視窗）
來源: J Vasc Surg 2003;37(2):453-5.
檢索: PubMed 12563221
DOI碼: 10.1067/mva.2003.73
Intravenous iron in heart failure: beyond targeting anemia. （開啟新視窗）
來源: Curr Heart Fail Rep 2011;8(1):14-21.
檢索: PubMed 21057903
DOI碼: 10.1007/s11897-010-0034-4
Cardiovascular surgery in Jehovah's Witness patients: the role of preoperative optimization. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2015;150(4):976-83.e1-3.
檢索: PubMed 26211405
DOI碼: 10.1016/j.jtcvs.2015.06.059
Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. （開啟新視窗）
來源: J Nephrol 2008;21(2):236-42.
檢索: PubMed 18446719
Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2010;139(3):621-7.
檢索: PubMed 20042202
DOI碼: 10.1016/j.jtcvs.2009.10.012
A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. （開啟新視窗）
來源: Transfusion 2015;55(7):1644-54.
檢索: PubMed 25702777
DOI碼: 10.1111/trf.13027
Blood conservation strategies can be applied safely to high-risk complex aortic surgery. （開啟新視窗）
來源: J Cardiothorac Vasc Anesth 2015;29(3):703-9.
檢索: PubMed 25847415
DOI碼: 10.1053/j.jvca.2014.10.022
Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. （開啟新視窗）
來源: Anesthesiology 2011;115(5):929-37.
檢索: PubMed 22027622
DOI碼: 10.1097/ALN.0b013e318232004b